bioRxiv · 10.1101/2024.12.11.627785
An artificial intelligence-based model for prediction of Clonal Hematopoiesis mutants in cell-free DNA samples
Abstract
Circulating tumor DNA is a critical biomarker in cancer diagnostics, but its accurate interpretation requires careful consideration of clonal hematopoiesis (CH), which can contribute to variants in cell-free DNA and potentially obscure true tumor-derived signals. Accurate detection of somatic variants of CH origin in plasma samples remains challenging in the absence of matched white blood cells sequencing. Here we present an open-source machine learning framework (MetaCHIP) which classifies variants in cfDNA from plasma-only samples as CH or tumor origin, surpassing state-of-the-art classification rates.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Arango-Argoty, G., Haghighi, M., Sun, G. J., Markovets, A., Barrett, J. C., Lai, Z., Jacob, E.. 2024-12-16. An artificial intelligence-based model for prediction of Clonal Hematopoiesis mutants in cell-free DNA samples. https://doi.org/10.1101/2024.12.11.627785
Cite the original work for its findings. Save a collection to share your selection of sources.